Volume 13, Issue 5 (7-2015)                   IJRM 2015, 13(5): 305-310 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moghadam M, Khatami S R, Galehdari H. Association of androgen receptor GGN repeat length polymorphism and male infertility in Khuzestan, Iran. IJRM 2015; 13 (5) :305-310
URL: http://ijrm.ir/article-1-644-en.html
1- Department of Genetics, Faculty of Sciences, Shahid Chamran University, Ahvaz, Iran
2- Department of Genetics, Faculty of Sciences, Shahid Chamran University, Ahvaz, Iran , srkhatami@yahoo.com
Full-Text [PDF 335 kb]   (814 Downloads)     |   Abstract (HTML)  (2732 Views)
Full-Text:   (382 Views)
Introduction
 
Approximately 15-18% of couples are affected with infertility, which in 50% of these couples, male factor is responsible. Genetic components are major reasons for male infertility in spite of environmental factors. Failure in spermatogenesis is one of the common causes of infertility in men. Androgens, acting through the androgen receptor (AR), play a role in secondary sexual differentiation from the prenatal stages to the adulthood, including spermatogenesis (1). AR is fundamental for differentiation of the external genitalia and prostate during development. It is also responsible for the changes that occur at puberty in males and maturation of spermatides and their differentiation (2). AR has three functional domains: N-terminal transactivating domain, DNA binding domain and C-terminal hormone binding domain. Transactivating domain is the most polymorphic domain in AR, because of two polymorphic amino acid tracts: polyglutamine tract and polyglycin stretch (3).
AR gene, including eight exons, is located on Xq 11-12 (4). The gene has two polymorphic sites in the first exon (5, 6). One of them is a long polymorphic trinucleotide (GGN) repeats with a common sense codon sequence of GGN tract (GGT)3 GGG (GGT)2 (GGC)4-25 which encodes polyglycin. The other polymorphic repeat is (CAG) 9-34 CAA that is called CAG repeat and locates in 5' portion of the first exon and it is responsible for encoding polyglutamine tract. Although CAG repeat length has been well studied in different populations but the data about GGN repeat is still incomplete. The number of CAG and GGN repeat ranges from about 10-35 (with a mean of 20-23) and 10-30 (with a mean of 20-21) respectively in normal men (7). CAG repeat regulates the transcriptional activity of AR protein (8).
Longer CAG repeat lengths cause reduced AR transcriptional activity both in vivo and in vitro, and it is clear that there is an inverse correlation between CAG number and androgenicity (9). Because of technical difficulties, GGN repeats have been sequenced rarely and unlike CAG repeat that has been the subject of many studies, these repeats are less examined. However there is in vitro evidence that proves glycine repeats have role in trans activity of AR protein, and deletion of GGN repeat reduces AR activity by ~30% (7, 10). Due to difficulties of GC-rich regions PCR amplification, investigation in GGN trinucleotide repeats is relatively less than CAG repeats, and its exact function is still unclear. The association between GGN and infertility was examined in few studies.
Tut et al reported no significance difference in distributions of GGN repeat lengths between infertile men and healthy individuals (9). Lundin et al found that distributions of the 23 and 24 GGN repeat alleles did not differ significantly between infertile men with sperm count <5×106 ml and controls (3). Ferlin et al, Ruhayel et al, Rajendar et al, Akinloye et al, and Nallar et al did not observe any differences in GGN repeat length between fertile and infertile men (1, 5, 6, 11, 12). In some of these studies the mutual effect of both repeats on male infertility was studied; "protective" and "at risk" CAG/GGN haplotypes were determined. The results showed the “protective” and the “at risk” CAG/GGC haplotypes were different (5, 6).
Despite the important role of GGN repeats, there are a limit number of studies on them; due to our knowledge no study has been done to determine the role of GGN repeats in male infertility in Iran. Therefore, we decided to investigate the GGN repeat lengths in Khuzestan, the southwest province of Iran, in order to find any relationship between the length of these repeats and idiopathic male infertility.
 
Materials and methods
 
According to the Cochrane sample size formula, 72 idiopathic infertile men (Arab or non-Arab), ranged between 33 to 39 years and less than 15×106 spermatozoia in 1ml of their semen admitted to the Imam Khomeini hospital and Shafa hospital of Ahvaz, Khuzestan, Iran were enrolled in our case control study. Cases with male accessory gland infections, hypogonadotropic hypogonadism, clinical varicocele, rectractile testis, genital trauma, drug consumption or concomitant hormonal treatment and Y chromosome microdeletions (investigated in three regions (AZFa, AZFb, and AZFc) by six Sequence Tagged Sites (STS) markers) were excluded.
The 72 samples were divided into two groups based on sperm count parameters: 36 individuals with azoospermia (absence of spermatozoia in their semen) and 36 individuals with oligozoospermia (<15×106 spermatozoia in 1 ml). 72 men, ranged between 32 to 38 years, who had at least one child, were included in our study as the control group. All participants gave their informed consent prior to their inclusion into the study with confirmation of research council of genetics department.
DNA extracted from peripheral blood cells using standard technique. Polymerase chain reaction (PCR) using following primers amplified GGN segment: F: 5'-AGAAGGCCA GTTGTATGGACC-3' and R: 5'-TGGGATAGG GCACTCTGCTCA-3'. Whereas this PCR product is a GC rich DNA fragment, the standard PCR and use of common additive such as DMSO, Formamide, Betain, etc. were unable to amplify this region. We established a new protocol by using 100µM 7-deazaguanine, 2 M Betaine (SIGMA ALDRICH, USA), 200 μM dATP, 200 μm dCTP, 200 μM dTTP (BIORON GmbH, Germany), 2mM MgCl2,100 μM dGTP 1x GC PCR buffer and 2 unit LA-Taq (TaKaRa Bio Inc, Japan).
We used 0.75 pM of each designed primers and 300 ng sample DNA in a total of 25µ reaction mixture. This PCR consisted of an initial denaturation step of 5 min at 94oC, followed by 30 cycles of 1 min denaturation at 94oC, 45 sec annealing at 62oC and extension step at 72oC for 30 sec and 7 min final elongation was performed at 72oC. The PCR products were run on 12% polyacrylamide gel and were sub grouped according to product length. One PCR product was selected from each group and was sequenced in order to determine GGN repeat size.
 
Statistical analysis
The statistical significance of the results between different groups, due to the abnormal distribution of GGN repeat lengths, were calculated using Mann-Whitney U test by Statistical Package for the Social Sciences, version 16.0, SPSS Inc., Chicago, Illinois, USA.
 
Results
 
Our findings showed that the number of GGN repeats ranged from 18-27 and from 20 to 28 respectively in infertile and fertile men. Figure 1 is a representative of all gel electrophoresis. Each of the alleles with 18, 20, and 28 repeats was observed in one individual, so most of alleles ranged from 21 to 27 repeats. The statistical analysis revealed that GGN repeat lengths differed significantly among cases and controls (p=0.015). Cases were distributed in seven different GGN alleles and most common GGN allele had 24 repeats, whereas eight GGN alleles were found in control group with the most frequent allele of 25 repeats (Figure 2).
Alleles with 20 and 28 repeats, which are present in two normal individuals, are absent in case group. In the other hand allele with 18 repeats was absent in control group. Although more than 58% of infertile individuals had the same GGN repeat lengths of 24 repeats, the distribution of GGN repeat lengths were far more symmetrical in control group. Due to our data, there was a strong correlation between allele with 24 repeats and infertility (p=0.015. The allele frequencies are shown in table I.
Since ethnic origin play a major role in function of many polymorphisms, our participants were divided into two groups, Arab and non-Arab, according to their ethnicity. As AR gene is located on X chromosome our cases were divided based on their mother's ethnicity. We found no significant differences between Arab and non-Arab groups (p=0.234). AR alleles in all participants distributed in 9 alleles in the Khuzestan population. Most common alleles among all samples were alleles with 24 and 25 GGN repeats (40.2% and 20.8% respectively).


Table I. The allele frequencies in different categories













Discussion
 
There are many studies on AR gene as a responsible factor for spermatogenesis failure, but the role of polymorphic repeats in male infertility is unclear.
In this study we analyzed GGN repeat lengths in 72 idiopathic infertile men and 72 fertile men. We found that alleles with 24 and 25 GGN repeats are the most common alleles in infertile and fertile men, respectively. Other studies have revealed that dominant alleles have been 23 and 24 GGN repeats in Indian population and 21 and 22 GGN repeats among Italian men (1,5). We found a significant association between AR gene GGN repeat lengths and infertility in Iranian men; while previous studies on GGN repeat lengths in other population showed no association with infertility while a study on Chinese infertile men revealed association of shorter GGN repeats with idiopatic infertility(13,14). This controversy could be explained via the principle that an identical polymorphism may have different effect on different ethnicities. The predominant allele in our infertile group was the allele with 24 repeats (58.3%) while the frequency of this allele in fertile group was 22.2%. This shows a significant association between the presence of allele with 24 repeats and susceptibility to male infertility.
In addition to this result of our study there is another study which shows a probable contribution of GGN 24 allele to AR dysfunction, which is in correlation with cryptorchidism and spermatogenic failure (12). Studies based on GGN repeat lengths in other diseases, have shown different results: Some studies on prostate cancer have detected no association and others have reported a correlation between shorter GGN repeats and higher risk of prostate cancer (15-20). Such contradictory results also have been observed in studies on cryptorchydism and hypospodias (21-23). Moreover, distinct findings have been announced for breast cancer (24-26). Complete androgen insensitivity syndrome and hypospodias were associated with longer alleles of GGN and CAG repeats (27). On the other hand, shorter GGN repeats could also increase the rate of recurrent spontaneous abortion (28). Therefore the role of the GGN repeat in AR function is still unclear and more investigations are required.
Since ethnical differences may affect the phenotypes resulted from an identical polymorphism, we investigated GGN repeat numbers in our case and control groups according to ethnicity. We determined GGN repeat lengths in Arab and non-Arab fertile and infertile men (mean of GGN in Arab infertile men: 23.67±0.316; non-Arab infertile men: 24.05±0.221; Arab fertile men: 24.37±0.373; non-Arab fertile men: 24.24±0.289). The most frequent GGN repeat lengths in Arab fertile men were 24 and 25 but the most common alleles in non-Arab fertile men were alleles with 25 and 26 GGN repeats.
On the other hand, the most prevalent GGN repeat length in Arab and non-Arab infertile men, was the allele with 24 repeats.Our finding showed that GGN repeat numbers have no significant difference between Arab and non-Arab men in fertile and infertile groups.
 Androgens are known to play role in spermatogenesis and sperm differentiation, therefore alterations in androgen receptor could affect spermatogenesis (29).
There are two statements that demonstrate how GGN repeat lengths could affect AR function. The first one explains how shorter GGN repeats can impair ligand binding and have negative effect on androgen dependent tissues (30). The second statement demonstrates that any alterations in GGN repeat lengths can change mRNA folding. These changes could affect AR mRNA translation and desensitize cells to androgens (23,31,32). It seems that our data of relationship between shorter GGN repeats and infertility confirms these statements.
 
Conclusion
 
In conclusion, the GGN repeat length in AR gene can affect the risk of men infertility. However more in vivo and in vitro investigations are required to reveal the role of GGN repeat polymorphism in androgen receptor activity, specifically allele with 24 repeats should considered.
 
Acknowledgments
 
This project was supported in part by grant No. 44305 of the Shahid Chamran University of Ahvaz, Iran. It is our great pleasure to thank Dr. Haghpanah for statistical analysis help. We also thank Blood Transfusion Center of Ahvaz for kindly providing fertile blood samples.
 
Conflict of interest
 
The authors declare that they have no conflict of interests.

 
Type of Study: Original Article |

References
1. Rajender S, Rajani V, Gupta NJ, Chakravarty B, Singh L, Thangaraj K. No association of androgen receptor GGN repeat length polymorphism with infertility in Indian men. J Androl 2006; 27: 785-789. [DOI:10.2164/jandrol.106.000166]
2. Haqq CM, Donahoe PK. Regulation of sexual dimorphism in mammals. Physiol Rev 1998; 78: 1-33. [DOI:10.1152/physrev.1998.78.1.1]
3. Lundin KB, Giwercman A, Richthoff J, Abrahamsson PA and Giwercman YL. No association between mutations in the human androgen receptor GGN repeat and inter-sex conditions. Mol Hum Reprod 2003; 9: 375-379. [DOI:10.1093/molehr/gag048]
4. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS and Wilson EM. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988; 240: 327-330. [DOI:10.1126/science.3353727]
5. Ferlin A, Bartoloni L, Rizzo G, Roverato A, Garolla A and Foresta C. Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Mol Hum Reprod 2004; 10: 417-421. [DOI:10.1093/molehr/gah054]
6. Ruhayel Y, Lundin K, Giwercman Y, Hallden C, Willen M and Giwercman A. Androgen receptor gene GGN and CAG polymorphisms among severely oligozoospermic and azoospermic Swedish men. Hum Reprod 2004; 19: 2076-2083. [DOI:10.1093/humrep/deh349]
7. Lumbroso R, Beitel LK, Vasiliou DM, Trifiro MA and Pinsky L. Codon-usage variants in the polymorphic (GGN)n trinucleotide repeat of the human androgen receptor gene. Hum Genet 1997; 101: 43-46. [DOI:10.1007/s004390050583]
8. Chamberlain NL, Driver ED and Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994; 22: 3181-3186. [DOI:10.1093/nar/22.15.3181]
9. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L and Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 1997; 82: 3777-3782. [DOI:10.1210/jc.82.11.3777]
10. McPhaul MJ. Molecular defects of the androgen receptor. J Steroid Biochem Mol Biol 1999; 69: 315-322. [DOI:10.1016/S0960-0760(99)00050-3]
11. Akinloye O, Gromoll J, Nieschlag E and Simoni M. Androgen receptor gene CAG and GGN polymorphisms in infertile Nigerian men. J Endocrinol Invest 2009; 32: 797-804. [DOI:10.1007/BF03345748]
12. Castro-Nallar E, Bacallao K, Parada-Bustamante A, Lardone MC, Lopez PV, Madariaga M, et al. Androgen receptor gene CAG and GGN repeat polymorphisms in Chilean men with primary severe spermatogenic failure. J Androl 2010; 31: 552-529. [DOI:10.2164/jandrol.109.008821]
13. Parada-Bustamante A, Lardone MC, Valdevenito R, Ebensperger M, Lopez PV, Madariaga M, et al. Analysis of 6 single-nucleotide polymorphisms in the androgen receptor gene in Chilean patients with primary spermatogenic failure. J Androl 2012; 33: 88-95. [DOI:10.2164/jandrol.110.012195]
14. Han TT, Ran J, Ding XP, Li LJ, Zhang LY, Zhang YP, et al. Cytogenetic and molecular analysis of infertile Chinese men: karyotypic abnormalities, Y-chromosome microdeletions, and CAG and GGN repeat polymorphisms in the androgen receptor gene. Genet Mol Res 2013; 12: 2215-2226. [DOI:10.4238/2013.July.8.3]
15. Correa-Cerro L, Wohr G, Haussler J, Berthon P, Drelon E, Mangin P, et al. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 1999; 7: 357-362. [DOI:10.1038/sj.ejhg.5200298]
16. Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, et al. Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 1033-1040.
17. Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S and Barrack ER. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 1997; 3: 1599-1608.
18. Lange EM, Sarma AV, Ray A, Wang Y, Ho LA, Anderson SA, et al. The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study. J Hum Genet 2008; 53: 220-226. [DOI:10.1007/s10038-007-0240-4]
19. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997; 57: 1194-1198.
20.   20. Zeegers MP, Kiemeney LA, Nieder AM and Ostrer H. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 2004; 13: 1765-1771.
21. Aschim EL, Nordenskjold A, Giwercman A, Lundin KB, Ruhayel Y, Haugen TB, et al. Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. J Clin Endocrinol Metab 2004; 89: 5105-5109. [DOI:10.1210/jc.2004-0293]
22. Ferlin A, Garolla A, Bettella A, Bartoloni L, Vinanzi C, Roverato A, et al. Androgen receptor gene CAG and GGC repeat lengths in cryptorchidism. Eur J Endocrinol 2005; 152: 419-425. [DOI:10.1530/eje.1.01860]
23. Radpour R, Rezaee M, Tavasoly A, Solati S and Saleki A. Association of long polyglycine tracts (GGN repeats) in exon 1 of the androgen receptor gene with cryptorchidism and penile hypospadias in Iranian patients. J Androl 2007; 28: 164-169. [DOI:10.2164/jandrol.106.000927]
24. Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, Healey CS, et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 1999; 20: 2131-2135. [DOI:10.1093/carcin/20.11.2131]
25. Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, et al. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer 2001; 85: 36-40. [DOI:10.1054/bjoc.2001.1777]
26. Suter NM, Malone KE, Daling JR, Doody DR and Ostrander EA. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 2003; 12: 127-135.
27. Omrani MD. Androgen receptor gene trinucleotide repeats as a marker for tracing disease in afamily with intersex patients. Iran J Reprod Med 2006; 4: 4.
28. Chuan Z, Jie D, Hao X, Junhua B, Mengjing G, Liguo P, et al. Associations between androgen receptor CAG & GGN repeat polymorphism & recurrent spontaneous abortions in Chinese women. Indian J Med Res 2014; 139: 730-736.
29. Zirkin BR, Santulli R, Awoniyi CA and Ewing LL. Maintenance of advanced spermatogenic cells in the adult rat testis: quantitative relationship to testosterone concentration within the testis. Endocrinology 1989; 124: 3043-3049. [DOI:10.1210/endo-124-6-3043]
30. Brinkmann AO, Blok LJ, de Ruiter PE, Doesburg P, Steketee K, Berrevoets CA, et al. Mechanisms of androgen receptor activation and function. J Steroid Biochem Mol Biol 1999; 69: 307-713. [DOI:10.1016/S0960-0760(99)00049-7]
31. Jasinska A, Michlewski G, de Mezer M, Sobczak K, Kozlowski P, Napierala M, et al. Structures of trinucleotide repeats in human transcripts and their functional implications. Nucleic Acids Res 2003; 31: 5463-5468. [DOI:10.1093/nar/gkg767]
32. Yeap BB, Wilce JA and Leedman PJ. The androgen receptor mRNA. Bioessays 2004; 26: 672-682. [DOI:10.1002/bies.20051]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb